AVITA Medical, Inc. (AVH.AX)
| Previous close | 4.7300 |
| Open | 4.7400 |
| Bid | 4.7200 x 734600 |
| Ask | 4.7400 x 258500 |
| Day's range | 4.6900 - 4.7600 |
| 52-week range | 4.4000 - 7.4000 |
| Volume | 97,856 |
| Avg. volume | 323,251 |
| Market cap | 587.541M |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3180 |
| Earnings date | 29 Apr 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.21 |
- GlobeNewswire
AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference
VALENCIA, Calif., and MELBOURNE, Australia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will present at the 2021 Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 4:00 p.m. Eastern Daylight Time / Tuesday, September 28, 2021 a
- GlobeNewswire
AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference
VALENCIA, Calif., and MELBOURNE, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will participate at the Lake Street 2021 BIG5 Conference on Tuesday, September 14, 2021. Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.
- GlobeNewswire
AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results
VALENCIA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported financial results for its fourth quarter of fiscal year 2021, ended June 30, 2021. Fourth Quarter of Fiscal Year 2021 Highlights Total net revenue increased 166% to $10.3 million compared to $3.9 million
